Evaluation of the Nodal Status in the 7th Edition of the UICC-TNM Classification for Esophageal Squamous Cell Carcinoma: Proposed Modifications for Improved Survival Stratification
Authors:
- 14 April 2014
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (9) , 2850-2856
Abstract
The 7th edition of the Union for International Cancer Control-TNM (UICC-TNM) classification for esophageal carcinoma made considerable modifications to the definition of N-staging by the number of involved lymph nodes and the regional node boundary. There were few validations of the regional boundary. We evaluated the nodal status of this classification for esophageal squamous cell carcinoma (ESCC). There were 665 patients reviewed who had ESCC and underwent esophagectomy between 1997 and 2012. We evaluated the impact of the location of lymph node metastasis on overall survival. There were 414 patients (61.7 %) who had lymph node metastases. The overall 5-year survival rate was 54.7 %. There were no significant differences in survival among N2, N3, and M1 patients. Cox regression analysis revealed that common hepatic or splenic node involvements (P = 0.001), pT stage (P = 0.0002), and pN stage (P < 0.0001) were independent predictors of survival, but supraclavicular node involvement (P = 0.29) was not. We propose a modified nodal status that designates supraclavicular node as regional: m-N0 (5-year survival = 79 %; n = 251); m-N1 (5-year = 56 %; n = 212); m-N2 (5-year = 30 %; n = 114); m-N3 (5-year = 18 %; n = 52); m-M1 (5-year = 6.2 %; n = 36). This modified nodal staging predicts survival better than the current staging system. The modification of supraclavicular lymph node from nonregional to regional in the 7th UICC classification of ESCC may allow for better stratification of overall survival.Keywords
This publication has 27 references indexed in Scilit:
- Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal CancerAnnals of Surgical Oncology, 2012
- Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the EsophagusOncology, 2011
- Comparison of Survival and Recurrence Pattern Between Two-Field and Three-Field Lymph Node Dissections for Upper Thoracic Esophageal Squamous Cell CarcinomaJournal of Thoracic Oncology, 2010
- p53 Genotype Predicts Response to Chemotherapy in Patients with Squamous Cell Carcinoma of the EsophagusAnnals of Surgical Oncology, 2009
- p53 Mutation Status Predicts Pathological Response to Chemoradiotherapy in Locally Advanced Esophageal CancerAnnals of Surgical Oncology, 2009
- Predicting Systemic Disease in Patients With Esophageal Cancer After EsophagectomyAnnals of Surgery, 2008
- Esophageal Carcinoma with Celiac Nodal Metastases; Curative or Palliative?Journal of Thoracic Oncology, 2008
- Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging SystemThe Annals of Thoracic Surgery, 2007
- A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodesJournal of Surgical Oncology, 2006
- Prognosis After Surgical Resection of M1a/M1b Esophageal Squamous Cell CarcinomaJournal of Korean Medical Science, 2005